Innovation & Devices
Bravo CF Recall Requires Removal From Esophageal Testing
The FDA’s Class I classification means gastroenterology and motility services should identify, quarantine and remove affected Bravo CF delivery devices while reviewing scheduled esophageal pH studies.
Rayan Salih · October 14, 2026 · 6 min